DT&CRO CO., Ltd. (KOSDAQ:383930)

DT&CRO CO. Revenue

DT&CRO CO. had revenue of 11.29B KRW in the quarter ending June 30, 2026, with 12.28% growth. This brings the company's total for the last twelve months to 49.00B, up 15.85% year-over-year. In the year 2025, DT&CRO CO. had annual revenue of 47.75B with 32.74% growth. That makes DT&CRO CO. the 29,997th largest company in the world by revenue and 1,878th in South Korea.

• Revenue (ttm): 49.00B
• Revenue Growth: +15.85%
• P/S Ratio: 0.56
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 27.42B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

• Safety 14.34B 39.9%
• Clinical 11.66B 32.4%
• Analysis 7.00B 19.5%
• Efficacy 2.97B 8.3%

By Geography

• South Korea 35.87B 99.7%
• Overseas 98.68M 0.3%

Fiscal year ended Dec 31, 2024 See the full DT&CRO CO. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	47.75B	11.78B	32.74%
Dec 31, 2024	35.97B	9.38B	35.30%
Dec 31, 2023	26.59B	-17.42B	-39.59%
Dec 31, 2022	44.01B	11.26B	34.38%
Dec 31, 2021	32.75B	12.66B	63.02%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error